Pamela P. Palmer
2023
In 2023, Pamela P. Palmer earned a total compensation of $814.3K as Chief Medical Officer at AcelRx Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,946 |
|---|---|
| Option Awards | $51,092 |
| Salary | $542,252 |
| Stock Awards | $10,780 |
| Other | $13,200 |
| Total | $814,270 |
Palmer received $542.3K in salary, accounting for 67% of the total pay in 2023.
Palmer also received $196.9K in non-equity incentive plan, $51.1K in option awards, $10.8K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Pamela P. Palmer's compensation ranked 1,356th out of 2,647 executives tracked by ExecPay. In other words, Palmer earned more than 48.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,356 out of 2,647 | 49th |
Division Manufacturing | 808 out of 1,447 | 44th |
Major group Chemicals And Allied Products | 526 out of 817 | 36th |
Industry group Drugs | 512 out of 783 | 35th |
Industry Pharmaceutical Preparations | 353 out of 555 | 36th |
Source: SEC filing on April 29, 2024.
Palmer's colleagues
We found two more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2023.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019